Physicians at the University of Colorado Hospital are finding startling success with medications that are made to match the genes of a particular lung cancer. The new strategy means the drugs work only on certain patients – but they can work really well. Researchers think the cancer-fighting drugs may tamp the disease for a few years, and then the cancers may mutate and find a way around the medication. But years of healthy living is fantastic for people who’ve been diagnosed with Stage 4 lung cancer, which has a five-year survival rate of less than 3 percent. Dr. Ross Camidge of UCH says patient Andy Bonnett is a prime example of what one of this new strategy of “personalized medicine” can do. Two years ago Bonnett was one of those Stage 4 lung cancer patients. He was, said Camidge, “a young man who had never smoked, led a very healthy life, developed increasing shortness of breath and pain, and was diagnosed with lung cancer in his mid-30s.”
Andy Bonnett is Changing the Face of Lung cancer! from TEAM DRAFT on Vimeo.